Skip to content

Effect of cyproheptadine on headache and hypotension after spinal anesthesia

Preventive effect of cyproheptadine in preventing headache and hypotension in spinal anesthesia in patients undergoing spinal anesthesia

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20211218053439N1
Enrollment
56
Registered
2022-02-22
Start date
2022-02-20
Completion date
Unknown
Last updated
2022-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal anesthesia induced headache and hypotension. -

Interventions

Intervention 1: Intervention group: Receiving cyproheptadine tablets with a dose of 4 mg and single dose orally. Intervention 2: Control group: receiving single-dose ciproheptadine placebo tablets ora

Sponsors

Islamic Azad University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: Surgery under spinal anesthesia Elective surgery American Society of Anesthesiologists(ASA) class I Age between 20 and 70 years

Exclusion criteria

Exclusion criteria: Reluctance to participate in the study Having any underlying disease Emergency surgery

Design outcomes

Primary

MeasureTime frame
Spinal anesthesia-induced headache. Timepoint: Evaluation of headache at the beginning of the study (before surgery) and 24 and 48 hours after surgery. Method of measurement: Through questionnaire.;Spinal anesthesia-induced hypotension. Timepoint: Measurement of blood pressure at the beginning of the study (before surgery) and 24 and 48 hours after surgery. Method of measurement: Blood pressure monitoring.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Farhadi

Islamic Azad University

sabafarhadi9675@gmail.com+98 23 3220 1378

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026